S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
OTCMKTS:ITHUF

iAnthus Capital Stock Forecast, Price & News

$0.26
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.22
Now: $0.26
$0.27
50-Day Range
$0.19
MA: $0.33
$0.46
52-Week Range
$0.05
Now: $0.26
$0.79
Volume853,036 shs
Average Volume1.82 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
iAnthus Capital Holdings, Inc. develops, owns, and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. Its products include smokable flower and pre-rolls; concentrates, such as vaporizer cartridges, wax products, tinctures, topicals, etc.; cannabis infused edibles; and various cannabidiol (CBD) products. The company also distributes and retails CBD products to dispensaries and retail stores, as well as online. As of July 31, 2020, it operated 36 dispensaries in 11 states. The company is based in Vancouver, Canada.

Headlines

iAnthus Announces Filing of Form 10 Registration Statement
December 8, 2020 |  finance.yahoo.com
Recent Trading Activity of iAnthus Stock
December 4, 2020 |  finance.yahoo.com
iAnthus Capital Holdings, Inc. (ITHUF)
November 1, 2020 |  finance.yahoo.com
Final Court Order Hearing
September 18, 2020 |  finance.yahoo.com
Ianthus Capital EPS misses by $1.21, beats on revenue
August 14, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ITHUF
CUSIPN/A
CIKN/A
Phone646-518-9411
Employees233
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.58 out of 5 stars

Medical Sector

1377th out of 1,969 stocks

Drug Manufacturers - Specialty & Generic Industry

30th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.26
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ITHUF News and Ratings via Email

Sign-up to receive the latest news and ratings for ITHUF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iAnthus Capital (OTCMKTS:ITHUF) Frequently Asked Questions

Is iAnthus Capital a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iAnthus Capital in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" iAnthus Capital stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITHUF, but not buy additional shares or sell existing shares.
View analyst ratings for iAnthus Capital
or view top-rated stocks.

What stocks does MarketBeat like better than iAnthus Capital?

Wall Street analysts have given iAnthus Capital a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iAnthus Capital wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has iAnthus Capital's stock price been impacted by COVID-19 (Coronavirus)?

iAnthus Capital's stock was trading at $0.5282 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ITHUF shares have decreased by 50.8% and is now trading at $0.26.
View which stocks have been most impacted by COVID-19
.

Who are iAnthus Capital's key executives?

iAnthus Capital's management team includes the following people:
  • Mr. Randy Maslow, Co-Founder, Pres, MD, Interim CEO & Director (Age 65, Pay $600k)
  • Mr. Julius John Kalcevich, CFO & Corp. Sec. (Age 47, Pay $450k)
  • Mr. Robert R. Galvin, Sr. VP, Chief Admin. Officer & Interim COO (Age 60)
  • Ms. Megan W. Kulick CFA, VP of Investor Relations
  • Dr. Richard J. Boxer, Chief Medical Officer
  • Mr. Michael R. Woolston, Sr. VP of Manufacturing, Supply Chain & Quality

Who are some of iAnthus Capital's key competitors?

What is iAnthus Capital's stock symbol?

iAnthus Capital trades on the OTCMKTS under the ticker symbol "ITHUF."

How do I buy shares of iAnthus Capital?

Shares of ITHUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iAnthus Capital's stock price today?

One share of ITHUF stock can currently be purchased for approximately $0.26.

How many employees does iAnthus Capital have?

iAnthus Capital employs 233 workers across the globe.

What is iAnthus Capital's official website?

The official website for iAnthus Capital is www.ianthuscapital.com.

How can I contact iAnthus Capital?

The company can be reached via phone at 646-518-9411.


This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.